Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
LG Chem will receive totaling up to $95.5 million for the China rights
Sanjeev is currently the Country President for AstraZeneca Malaysia
The current ruling will assure the safety of the use of Ranitidine for Indian patients
Expressed happiness that more than 30 countries of the world have given recognition to Ayurveda as a traditional system of medicine
They also released the Operational Guidelines for Wellness activities at AB-HWCs
As per 10th edition of International Diabetes Federation (IDF) Atlas, 2021, India has 74.2 million people with diabetes between the age of 20-79 years
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
The 9th World Ayurveda Congress and Arogya Expo 2022 aims to showcase the efficacy and strength of the AYUSH systems of medicine at the global level
The approval follows the positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) in October 2022
Subscribe To Our Newsletter & Stay Updated
